Winston Pharmaceuticals, Inc. (WPHM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 14, 2025
Winston Pharmaceuticals Company Description
Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management.
It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications.
Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008.
The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.
Winston Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Joel Bernstein |
Contact Details
Address: 100 North Fairway Drive Vernon Hills, Illinois 60061 United States | |
| Phone | 847-362-8200 |
| Website | winstonlabs.com |
Stock Details
| Ticker Symbol | WPHM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US9756571074 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Joel E. Bernstein M.D. | Founder, Chief Executive Officer, President and Director |
| Barry R. Hollingsworth CFA, CPA | Chief Financial Officer |
| David A. Henninger M.S., R.A.C. | Vice President of Operations |